Uber stock is approaching a return to record highs after concerns about competition from Waymo and Tesla sunk its shares late ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Fidelity National Information Services (NYSE:FIS – Get Free Report)‘s stock had its “outperform” rating reissued by research ...

William Blair analyst Arjun Bhatia maintained a Buy rating on Radcom (RDCM – Research Report) today. The company’s shares opened today at ...

William Blair lifted their Q1 2025 earnings estimates for Watsco in a research report issued on Tuesday, February 18th. William Blair analyst R. Merkel now anticipates that the construction company ...

Fintel reports that on February 18, 2025, William Blair upgraded their outlook for Parsons (NYSE:PSN) from Market Perform to ...

William Blair International Growth Fund earns an Average Process Pillar rating. The main driver of the rating is the fund's excellent long-term risk-adjusted performance. This can be seen in its ...

Repligen Corp (NASDAQ:RGEN) released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago ...

Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company ...

William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John Ivey and B.T. Remmert as the ...